E 23 Pill - yellow round, 10mm
Pill with imprint E 23 is Yellow, Round and has been identified as Topiramate 100 mg. It is supplied by Aurobindo Pharma.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E 23
Topiramate
- Imprint
- E 23
- Strength
- 100 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- National Drug Code (NDC)
- 65862-0173
- Inactive Ingredients
-
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 400,
polysorbate 80,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "E 23"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,332)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.